BIND Therapeutics To Present At Cowen and Company 34th Annual Healthcare Conference

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

BIND Therapeutics, Inc. (NASDAQ:BIND), a clinical-stage nanomedicine platform company developing targeted and programmable therapeutics called AccurinsTM, announced today that Scott Minick, BIND’s President and CEO, is scheduled to present at the Cowen 34th Annual Healthcare Conference in Boston on Tuesday, March 4, 2014 at 10:40 a.m. ET.

Help employers find you! Check out all the jobs and post your resume.

Back to news